20
Polymed Therapeutics, Inc. Houston Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Paclitaxel, Produced by a semi-synthetic process, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-192 - Rev 00
This Chemical Type CEP, issued on June 29, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1794 associated with this CEP further emphasizes